Target intelligence / Profile preview

GABRG3 antisense RNA 1 (GABRG3-AS1)

Target: GABRG3-AS1
Molecular classification: Long non-coding RNA, Antisense RNA

Overview

GABRG3 antisense RNA 1 (GABRG3-AS1) is a primate-specific long non-coding RNA gene located on chromosome 15q12. It is transcribed antisense to the GABRG3 gene, which codes for the gamma3 subunit of the GABA-A receptor. While GABRG3 itself plays a critical role in inhibitory neurotransmission and has clear implications in neurological disorders, GABRG3-AS1 remains a transcript of unknown function. It is not a receptor, enzyme, transporter, or recognized therapeutic target. Most large databases list GABRG3-AS1 as an antisense non-coding RNA gene, with no established connection to regulated pathways, disease, or clinical biomarkers. Its primary scientific relevance is its locus and antisense relationship to a druggable protein (GABRG3), but further research is needed to clarify any physiological or pathological roles for GABRG3-AS1.

Other names: GABRG3-AS1GABRG3 antisense RNA 1

Mechanism of action

null

Biological functions

Unknown (Data insufficient for specific functional annotation. Genomic location and antisense regulation are possible, but no definitive biological role has been established)

Disease associations

Other (No current direct disease association established for GABRG3-AS1. GABRG3, its sense partner, is implicated in neurodevelopmental disorders such as Angelman syndrome and autism spectrum disorder, but GABRG3-AS1's involvement is speculative and not supported by direct evidence)

Beyond the preview

Go deeper on GABRG3 antisense RNA 1 (GABRG3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GABRG3 antisense RNA 1 (GABRG3-AS1).

Explore the full profile